Delivery Order SPE2DB20D3505-SPE2DB24FU8J7

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,414.56 firm fixed-price delivery order is for the supply of COPAXONE 20 MG/ML syringes, a medication used for the treatment of multiple sclerosis. The contract has an ultimate completion date of October 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distribution company. The $2,232.72 Firm Fixed Price Delivery Order is for the supply of Copaxone 40 mg/ml syringes, a prescription medication. The contract has an ultimate completion date of July 10, 2024 and is not set aside for any specific business category. Amerisourcebergen holds a much larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Copaxone 40 mg/ml syringes, a specialty pharmaceutical medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,638.80 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,055.52 fixed-price delivery order is for the supply of COPAXONE 40 MG/ML, a specialty pharmaceutical product. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This award is a $1,768.76 delivery order contract issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of COPAXONE 40 MG/ML SYRINGEML. The contract does not have a set-aside designation. This order is placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999, for delivering a broad range of medical commodities to support military treatment...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COPAXONE 40 MG/ML SYRINGEML, with a ceiling value of $1,092.00 and a period of performance through May 14, 2025. This delivery order is not set aside and is priced on a firm fixed-price basis. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,660.80 delivery order contract is for the supply of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product. The contract is a firm-fixed price delivery order, with an ultimate completion date of June 9, 2025. There is no set-aside designation for this award. AmerisourceBergen Drug Corp holds a significant...
The Defense Logistics Agency (DLA) awarded a $1,583.28 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of COPAXONE 40 MG/ML syringes. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of medical commodities to support military treatment programs and...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,583.28 firm fixed price delivery order contract (SPE2DX15D2109|SPE2DX24F0L9D) by the Defense Logistics Agency (DLA) Troop Support Medical to provide Copaxone 40 mg/ml syringes. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of COPAXONE 40 MG/ML SYRINGEML. The firm-fixed-price delivery order contract has a ceiling value of $2,122.56 and a completion date of June 12, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB24FU8J7
    Delivery Order

This federal contract award is a delivery order with a firm fixed price of $1,627.62 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for Copaxone 20 mg/ml syringes, a specialty medication, with a period of performance through August 20, 2024.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award reviewed was not designated with any set-aside requirements, indicating open competition. There is no information provided about any major subcontractors. The DLA is the primary funding agency, responsible for providing medical materiel to the U.S. Armed Forces, other federal agencies, and foreign countries.

Generated 2/27/25, 11:31 AM